Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Thomas Georgi(Leipzig University), Vladan Vučinić(University Hospital Leipzig), G Borte(Leipzig University), Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Lars Kurch, Klaus H. Metzeler(University Hospital Leipzig), Marco Herling(Unknown), Regine Kluge(Klinik und Poliklinik für Nuklearmedizin), Naima Petermann(Leipzig University), Madlen Jentzsch, Timm Denecke(Leipzig University), Carmen Perez‐Fernandez(Leipzig University), Uwe Platzbecker(National Center for Tumor Diseases), Maximilian Merz(Memorial Sloan Kettering Cancer Center), Sandra Hoffmann(Economic Research Service), Georg‐Nikolaus Franke(University Hospital Leipzig), Sebastian Schwind
Cited by 25
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease
|Circulation|2004|774
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655
Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
|Journal of Food Protection|2012|609